TrialEuropean heart journal2020

Comparison of interleukin-6, C-reactive protein, and low-density lipoprotein cholesterol as biomarkers of residual risk in contemporary practice: secondary analyses from the Cardiovascular Inflammation Reduction Trial.

Paul M Ridker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.